|
2014-05-16 |
2014-05-16 |
S
Sale
|
OCAMPO CHRISTINE
Vice President, Finance
Officer
|
11,900
-79.9%
4.88
USD 58,072
|
11,900
-79.9%
|
4.88
|
USD 58,072
|
|
|
2013-12-19 |
2013-12-17 |
B
Purchase
|
PALEKAR ROHAN
SVP & Chief Commercial Officer
Officer
|
10,000
+7.5%
2.80
USD 28,000
|
10,000
+7.5%
|
2.80
|
USD 28,000
|
|
|
2013-11-05 |
2013-11-04 |
B
Purchase
|
PALEKAR ROHAN
SVP & Chief Commercial Officer
Officer
|
10,000
+8.1%
4.19
USD 41,895
|
10,000
+8.1%
|
4.19
|
USD 41,895
|
|
|
2012-05-14 |
2012-05-10 |
B
Purchase
|
Siffert Joao MD
SVP, R&D
Officer
|
2,700
+9.2%
2.96
USD 7,992
|
2,700
+9.2%
|
2.96
|
USD 7,992
|
|
|
2012-03-07 |
2012-03-06 |
B
Purchase
|
MATHEWS CHARLES
Non-Executive Director
|
5,000
+inf%
2.69
USD 13,473
|
5,000
+inf%
|
2.69
|
USD 13,473
|
|
|
2012-03-07 |
2012-03-06 |
B
Purchase
|
OCAMPO CHRISTINE
Vice President, Finance
Officer
|
3,000
+inf%
2.60
USD 7,795
|
3,000
+inf%
|
2.60
|
USD 7,795
|
|
|
2010-11-10 |
2010-11-09 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1,200,000
-15.2%
4.81
USD 5,773,920
|
1,200,000
-15.2%
|
4.81
|
USD 5,773,920
|
|
|
2010-11-10 |
2010-11-08 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
44,626
-0.6%
5.10
USD 227,593
|
44,626
-0.6%
|
5.10
|
USD 227,593
|
|
|
2010-11-05 |
2010-11-05 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
332,572
-4.0%
4.80
USD 1,597,377
|
332,572
-4.0%
|
4.80
|
USD 1,597,377
|
|
|
2010-11-05 |
2010-11-03 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1,400,106
-14.5%
4.52
USD 6,332,539
|
1,400,106
-14.5%
|
4.52
|
USD 6,332,539
|
|
|
2010-11-02 |
2010-11-02 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1,290,871
-11.8%
4.49
USD 5,800,400
|
1,290,871
-11.8%
|
4.49
|
USD 5,800,400
|
|
|
2010-11-02 |
2010-11-01 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
2,478,142
-18.5%
5.36
USD 13,273,424
|
2,478,142
-18.5%
|
5.36
|
USD 13,273,424
|
|
|
2010-11-02 |
2010-10-29 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1,424,947
-9.6%
5.06
USD 7,215,647
|
1,424,947
-9.6%
|
5.06
|
USD 7,215,647
|
|
|
2010-10-12 |
2010-10-11 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
311,000
-2.1%
3.52
USD 1,093,445
|
311,000
-2.1%
|
3.52
|
USD 1,093,445
|
|
|
2010-10-12 |
2010-10-08 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
240,838
-1.6%
3.47
USD 836,792
|
240,838
-1.6%
|
3.47
|
USD 836,792
|
|
|
2010-07-15 |
2010-07-13 |
S
Sale
|
Clarus Lifesciences I, L.P.
Large shareholder
|
165,000
-1.1%
3.53
USD 583,143
|
165,000
-1.1%
|
3.53
|
USD 583,143
|
|
|
2009-10-13 |
2009-10-13 |
S
Sale
|
Moorin Jay
Large shareholder
|
547,135
-7.1%
2.23
USD 1,220,111
|
547,135
-7.1%
|
2.23
|
USD 1,220,111
|
|
|
2009-10-13 |
2009-10-12 |
S
Sale
|
Moorin Jay
Large shareholder
|
427,145
-5.3%
2.12
USD 905,547
|
427,145
-5.3%
|
2.12
|
USD 905,547
|
|
|
2009-10-13 |
2009-10-09 |
S
Sale
|
Moorin Jay
Large shareholder
|
804,712
-9.0%
2.46
USD 1,979,592
|
804,712
-9.0%
|
2.46
|
USD 1,979,592
|
|
|
2009-08-13 |
2009-08-11 |
S
Sale
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
232,450
-2.8%
3.37
USD 783,938
|
232,450
-2.8%
|
3.37
|
USD 783,938
|
|
|
2009-08-13 |
2009-08-11 |
S
Sale
|
Moorin Jay
Large shareholder
|
894,120
-9.1%
3.58
USD 3,200,950
|
894,120
-9.1%
|
3.58
|
USD 3,200,950
|
|
|
2009-08-13 |
2009-08-11 |
S
Sale
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
49,800
-0.6%
4.05
USD 201,690
|
49,800
-0.6%
|
4.05
|
USD 201,690
|
|
|
2009-08-03 |
2009-07-31 |
S
Sale
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
1,400
-0.0%
2.20
USD 3,080
|
1,400
-0.0%
|
2.20
|
USD 3,080
|
|
|
2009-08-03 |
2009-07-30 |
S
Sale
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
142,366
-1.7%
2.29
USD 326,445
|
142,366
-1.7%
|
2.29
|
USD 326,445
|
|
|
2009-08-03 |
2009-07-29 |
S
Sale
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
145,500
-1.7%
2.28
USD 331,245
|
145,500
-1.7%
|
2.28
|
USD 331,245
|
|
|
2009-08-03 |
2009-07-28 |
S
Sale
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
122,100
-1.4%
2.42
USD 295,714
|
122,100
-1.4%
|
2.42
|
USD 295,714
|
|
|
2008-10-24 |
2008-10-22 |
B
Purchase
|
Moorin Jay
Large shareholder
|
10,600
+0.1%
0.48
USD 5,088
|
10,600
+0.1%
|
0.48
|
USD 5,088
|
|
|
2008-10-15 |
2008-10-15 |
B
Purchase
|
Moorin Jay
Large shareholder
|
6,465
+0.1%
0.49
USD 3,168
|
6,465
+0.1%
|
0.49
|
USD 3,168
|
|
|
2008-10-15 |
2008-10-14 |
B
Purchase
|
Moorin Jay
Large shareholder
|
32,300
+0.3%
0.50
USD 16,150
|
32,300
+0.3%
|
0.50
|
USD 16,150
|
|
|
2008-10-15 |
2008-10-10 |
B
Purchase
|
Moorin Jay
Large shareholder
|
73,551
+0.8%
0.45
USD 33,098
|
73,551
+0.8%
|
0.45
|
USD 33,098
|
|
|
2008-10-10 |
2008-10-09 |
B
Purchase
|
Moorin Jay
Large shareholder
|
41,385
+0.4%
0.48
USD 19,865
|
41,385
+0.4%
|
0.48
|
USD 19,865
|
|
|
2008-10-10 |
2008-10-08 |
B
Purchase
|
Moorin Jay
Large shareholder
|
114,384
+1.2%
0.50
USD 57,192
|
114,384
+1.2%
|
0.50
|
USD 57,192
|
|
|
2008-10-10 |
2008-10-07 |
B
Purchase
|
Moorin Jay
Large shareholder
|
21,318
+0.2%
0.48
USD 10,233
|
21,318
+0.2%
|
0.48
|
USD 10,233
|
|
|
2008-09-17 |
2008-09-17 |
B
Purchase
|
Moorin Jay
Large shareholder
|
413,217
+4.5%
0.80
USD 330,574
|
413,217
+4.5%
|
0.80
|
USD 330,574
|
|
|
2008-09-17 |
2008-09-16 |
B
Purchase
|
Moorin Jay
Large shareholder
|
17,387
+0.2%
0.76
USD 13,214
|
17,387
+0.2%
|
0.76
|
USD 13,214
|
|
|
2008-09-17 |
2008-09-15 |
B
Purchase
|
Moorin Jay
Large shareholder
|
244,449
+2.8%
0.85
USD 207,782
|
244,449
+2.8%
|
0.85
|
USD 207,782
|
|
|
2008-09-10 |
2008-09-10 |
B
Purchase
|
Moorin Jay
Large shareholder
|
48,103
+0.5%
0.91
USD 43,774
|
48,103
+0.5%
|
0.91
|
USD 43,774
|
|
|
2008-09-10 |
2008-09-09 |
B
Purchase
|
Moorin Jay
Large shareholder
|
146,400
+1.7%
0.92
USD 134,688
|
146,400
+1.7%
|
0.92
|
USD 134,688
|
|
|
2008-09-10 |
2008-09-08 |
B
Purchase
|
Moorin Jay
Large shareholder
|
125,000
+1.5%
0.95
USD 118,750
|
125,000
+1.5%
|
0.95
|
USD 118,750
|
|
|
2008-09-04 |
2008-09-04 |
B
Purchase
|
Moorin Jay
Large shareholder
|
52,113
+0.6%
0.95
USD 49,507
|
52,113
+0.6%
|
0.95
|
USD 49,507
|
|
|
2008-09-04 |
2008-09-03 |
B
Purchase
|
Moorin Jay
Large shareholder
|
6,864
+0.1%
0.93
USD 6,384
|
6,864
+0.1%
|
0.93
|
USD 6,384
|
|
|
2008-09-04 |
2008-09-02 |
B
Purchase
|
Moorin Jay
Large shareholder
|
323,550
+4.0%
0.93
USD 300,902
|
323,550
+4.0%
|
0.93
|
USD 300,902
|
|
|
2008-08-29 |
2008-08-27 |
B
Purchase
|
Moorin Jay
Large shareholder
|
89,447
+1.1%
0.95
USD 84,975
|
89,447
+1.1%
|
0.95
|
USD 84,975
|
|
|
2008-08-18 |
2008-08-15 |
B
Purchase
|
Moorin Jay
Large shareholder
|
114,032
+1.4%
0.95
USD 108,330
|
114,032
+1.4%
|
0.95
|
USD 108,330
|
|
|
2008-08-18 |
2008-08-14 |
B
Purchase
|
Moorin Jay
Large shareholder
|
6,051
+0.1%
0.90
USD 5,446
|
6,051
+0.1%
|
0.90
|
USD 5,446
|
|
|
2008-08-08 |
2008-08-07 |
B
Purchase
|
Moorin Jay
Large shareholder
|
91,380
+1.2%
0.98
USD 89,552
|
91,380
+1.2%
|
0.98
|
USD 89,552
|
|
|
2008-08-08 |
2008-08-06 |
B
Purchase
|
Moorin Jay
Large shareholder
|
400
+0.0%
0.90
USD 360
|
400
+0.0%
|
0.90
|
USD 360
|
|
|
2006-06-07 |
2006-05-31 |
S
Sale
|
SILVERSTEIN JONATHAN
Non-Executive Director
|
629,121
-26.9%
9.79
USD 6,159,095
|
629,121
-26.9%
|
9.79
|
USD 6,159,095
|
|
|
2006-06-02 |
2006-05-31 |
B
Purchase
|
Podlesak Dennis
Non-Executive Director
|
200
+2.8%
9.91
USD 1,982
|
200
+2.8%
|
9.91
|
USD 1,982
|
|
|
2006-06-02 |
2006-05-31 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
629,121
-26.9%
9.79
USD 6,159,095
|
629,121
-26.9%
|
9.79
|
USD 6,159,095
|
|
|
2006-06-02 |
2006-05-31 |
B
Purchase
|
Podlesak Dennis
Non-Executive Director
|
800
+12.4%
9.90
USD 7,920
|
800
+12.4%
|
9.90
|
USD 7,920
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
Kaye Randall
VP of Medical Affairs
Officer
|
250
+inf%
9.90
USD 2,475
|
250
+inf%
|
9.90
|
USD 2,475
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
Kaye Randall
VP of Medical Affairs
Officer
|
200
+400.0%
9.90
USD 1,980
|
200
+400.0%
|
9.90
|
USD 1,980
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
Kaye Randall
VP of Medical Affairs
Officer
|
50
+inf%
9.89
USD 495
|
50
+inf%
|
9.89
|
USD 495
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
HANSON GREGORY P
Vice President, CAO
Officer
|
100
+2.0%
9.68
USD 968
|
100
+2.0%
|
9.68
|
USD 968
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
HANSON GREGORY P
Vice President, CAO
Officer
|
100
+2.0%
9.67
USD 967
|
100
+2.0%
|
9.67
|
USD 967
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
HANSON GREGORY P
Vice President, CAO
Officer
|
300
+6.4%
9.69
USD 2,907
|
300
+6.4%
|
9.69
|
USD 2,907
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
Kaye Randall
VP of Medical Affairs
Officer
|
2,000
+inf%
10.14
USD 20,280
|
2,000
+inf%
|
10.14
|
USD 20,280
|
|
|
2006-05-26 |
2006-05-26 |
B
Purchase
|
HANSON GREGORY P
Vice President, CAO
Officer
|
600
+14.8%
9.65
USD 5,790
|
600
+14.8%
|
9.65
|
USD 5,790
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
BRANDT ERIC
President, CEO & Director
Executive Director
|
89
+0.0%
8.96
USD 797
|
89
+0.0%
|
8.96
|
USD 797
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
BRANDT ERIC
President, CEO & Director
Executive Director
|
2,911
+1.1%
8.97
USD 26,112
|
2,911
+1.1%
|
8.97
|
USD 26,112
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
BRANDT ERIC
President, CEO & Director
Executive Director
|
1,700
+0.7%
8.99
USD 15,283
|
1,700
+0.7%
|
8.99
|
USD 15,283
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
PUNTORIERO MICHAEL J
Senior VP, Finance, CFO
Officer
|
2,500
+44.4%
9.00
USD 22,500
|
2,500
+44.4%
|
9.00
|
USD 22,500
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
Katkin Keith
Sr. V.P. of Sales & Marketing
Officer
|
1,700
+212.5%
9.00
USD 15,300
|
1,700
+212.5%
|
9.00
|
USD 15,300
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
BRANDT ERIC
President, CEO & Director
Executive Director
|
6,300
+2.5%
9.00
USD 56,700
|
6,300
+2.5%
|
9.00
|
USD 56,700
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
EMANUELE ROBERT MARTIN
V P, Business Development
Officer
|
1,000
+inf%
8.99
USD 8,990
|
1,000
+inf%
|
8.99
|
USD 8,990
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
PUNTORIERO MICHAEL J
Senior VP, Finance, CFO
Officer
|
5,000
+800.0%
9.05
USD 45,250
|
5,000
+800.0%
|
9.05
|
USD 45,250
|
|
|
2006-05-25 |
2006-05-25 |
B
Purchase
|
Katkin Keith
Sr. V.P. of Sales & Marketing
Officer
|
800
+inf%
8.98
USD 7,184
|
800
+inf%
|
8.98
|
USD 7,184
|
|
|
2006-02-22 |
2006-02-17 |
S
Sale
|
SIRCAR JAGADISH C
VP of Drug Discovery
Officer
|
3,600
-22.2%
16.82
USD 60,552
|
3,600
-22.2%
|
16.82
|
USD 60,552
|
|
|
2006-02-15 |
2006-02-14 |
B
Purchase
|
Mazzo David J
Non-Executive Director
|
1,000
+15.5%
15.59
USD 15,590
|
1,000
+15.5%
|
15.59
|
USD 15,590
|
|
|
2005-10-24 |
2005-10-20 |
B
Purchase
|
SILVERSTEIN JONATHAN
Non-Executive Director
|
566,038
+6.5%
2.65
USD 1,500,001
|
566,038
+6.5%
|
2.65
|
USD 1,500,001
|
|
|
2005-04-12 |
2005-04-08 |
B
Purchase
|
SILVERSTEIN JONATHAN
Non-Executive Director
|
900,000
+11.4%
2.20
USD 1,980,000
|
900,000
+11.4%
|
2.20
|
USD 1,980,000
|
|
|
2005-01-03 |
2005-01-03 |
PS
Planned sale
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Officer
|
10,200
-40.5%
3.40
USD 34,680
|
10,200
-40.5%
|
3.40
|
USD 34,680
|
|
|
2005-01-03 |
2005-01-03 |
PS
Planned sale
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Officer
|
4,800
-16.0%
3.39
USD 16,254
|
4,800
-16.0%
|
3.39
|
USD 16,254
|
|
|
2005-01-03 |
2005-01-03 |
PS
Planned sale
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Officer
|
600
-3.8%
3.42
USD 2,052
|
600
-3.8%
|
3.42
|
USD 2,052
|
|
